Photodynamic therapy ― coming of ageHENDERSON, B. W.Photodermatology. 1989, Vol 6, Num 5, pp 200-211, issn 0108-9684Article

Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cyclingWEI, L.-H; BAUMANN, H; TRACY, E et al.British journal of cancer. 2007, Vol 97, Num 11, pp 1513-1522, issn 0007-0920, 10 p.Article

How does photodynamic therapy work ?HENDERSON, B. W; DOUGHERTY, T. J.Photochemistry and photobiology. 1992, Vol 55, Num 1, pp 145-157, issn 0031-8655Article

A PWN inverter algorithm for adjustable speed AC drives using a nonconstant voltage sourceRAMSHAW, R. S; XIE, G; HENDERSON, B. W et al.IEEE transactions on industry applications. 1986, Vol 22, Num 4, pp 673-677, issn 0093-9994Conference Paper

Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapyHENDERSON, B. W; WALDOW, S. M; MANG, T. S et al.Cancer research (Baltimore). 1985, Vol 45, Num 2, pp 572-576, issn 0008-5472Article

BBS results for the iPSC/C and iPSC/860FOWLER, R. F; HENDERSON, B. W; GREENOUGH, C et al.FGCS. Future generations computer systems. 1995, Vol 11, Num 1, pp 49-59, issn 0167-739XConference Paper

Porting a three-dimensional semiconductor device modelling program to the Intel iPSC/860 hypercubeFOWLER, R. F; HENDERSON, B. W; GREENOUGH, C et al.FGCS. Future generations computer systems. 1995, Vol 11, Num 1, pp 61-70, issn 0167-739XConference Paper

Photosensitization with methylene-linked porphyrin dimersKESSEL, D; CHANG, C. K; HENDERSON, B. W et al.Journal of photochemistry and photobiology. B, Biology. 1993, Vol 18, Num 2-3, pp 177-180, issn 1011-1344Article

Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumorsMILLER, A. C; HENDERSON, B. W.Journal of the National Cancer Institute. 1986, Vol 77, Num 2, pp 505-510, issn 0027-8874Article

Loss of vascular fibrinolytic activity following irradiation of the liver. An aspect of late radiation damageHENDERSON, B. W; BICHER, H. I; JOHNSON, R. J et al.Radiation research. 1983, Vol 95, Num 3, pp 646-652, issn 0033-7587Article

Reduction of tumour oxygenation during and after photodynamic therapy in vivo : effects of fluence rateSITNIK, T. M; HAMPTON, J. A; HENDERSON, B. W et al.British journal of cancer. 1998, Vol 77, Num 9, pp 1386-1394, issn 0007-0920Article

Photodynamic therapy affects the expression of IL-6 and IL-10 in vivoGOLLNICK, S. O; MUSSER, D. A; HENDERSON, B. W et al.SPIE proceedings series. 1998, pp 19-26, isbn 0-8194-2693-8Conference Paper

Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivoGOLLNICK, S. O; LIU, X; OWCZARCZAK, B et al.Cancer research (Baltimore). 1997, Vol 57, Num 18, pp 3904-3909, issn 0008-5472Article

An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapyHENDERSON, B. W; BELLNIER, D. A; GRECO, W. R et al.Cancer research (Baltimore). 1997, Vol 57, Num 18, pp 4000-4007, issn 0008-5472Article

Induction of glucose regulated proteins during growth of a murine tumorCAI, J.-W; HENDERSON, B. W; SHEN, J.-W et al.Journal of cellular physiology. 1993, Vol 154, Num 2, pp 229-237, issn 0021-9541Article

Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-aBELLNIER, D. A; HENDERSON, B. W; PANDEY, R. K et al.Journal of photochemistry and photobiology. B, Biology. 1993, Vol 20, Num 1, pp 55-61, issn 1011-1344Article

Hyperthermic potentiation of photodynamic therapy employing photofrin 1 and II: comparison of results using three animal tumor modelsWALDOW, S. M; HENDERSON, B. W; DOUGHERTY, T. J et al.Lasers in surgery and medicine. 1987, Vol 7, Num 1, pp 12-22, issn 0196-8092Article

Interleukin-Iα is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblastsTRACY, E. C; BOWMAN, M. J; HENDERSON, B. W et al.British journal of cancer. 2012, Vol 107, Num 9, pp 1534-1546, issn 0007-0920, 13 p.Article

Role of cytokines in photodynamic therapy-induced local and systemic inflammationGOLLNICK, S. O; EVANS, S. S; BAUMANN, H et al.British journal of cancer. 2003, Vol 88, Num 11, pp 1772-1779, issn 0007-0920, 8 p.Article

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateHENDERSON, B. W; BUSCH, T. M; GRECO, W. R et al.Cancer research (Baltimore). 2000, Vol 60, Num 3, pp 525-529, issn 0008-5472Article

Effects of fluence rate on cytotoxicity during photodynamic therapySITNIK, T. M; HENDERSON, B. W.SPIE proceedings series. 1997, pp 95-102, isbn 0-8194-2383-1Conference Paper

Modes of cytotoxicity associated with photodynamic therapyKESSEL, D; LUO, Y; CHANG, C. K et al.SPIE proceedings series. 1997, pp 103-109, isbn 0-8194-2383-1Conference Paper

Release of prostaglandin E₂ from cells by photodynamic treatment in vitroHENDERSON, B. W; DONOVAN, J. M.Cancer research (Baltimore). 1989, Vol 49, Num 24, pp 6896-6900, issn 0008-5472, part 1Article

Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in miceFINGAR, V. H; MANG, T. S; HENDERSON, B. W et al.Cancer research (Baltimore). 1988, Vol 48, Num 12, pp 3350-3354, issn 0008-5472Article

Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changesFINGAR, V. H; POTTER, W. R; HENDERSON, B. W et al.Photochemistry and photobiology. 1987, Vol 45, Num 5, pp 643-650, issn 0031-8655Article